Home
>
National Drug Code (NDC)
>
Plasbumin
Plasbumin - 13533-692-20 - (Albumin (Human))
Drug Information of Plasbumin
| Product NDC: | 13533-692 |
| Proprietary Name: | Plasbumin |
| Non Proprietary Name: | Albumin (Human) |
| Active Ingredient(s): | 5 g/20mL & nbsp; Albumin (Human) |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Plasbumin
| Product NDC: | 13533-692 |
| Labeler Name: | Grifols Therapeutics Inc. |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA101138 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19940926 |
Package Information of Plasbumin
| Package NDC: | 13533-692-20 |
| Package Description: | 1 VIAL in 1 CARTON (13533-692-20) > 50 mL in 1 VIAL (13533-692-21) |
NDC Information of Plasbumin
| NDC Code | 13533-692-20 |
| Proprietary Name | Plasbumin |
| Package Description | 1 VIAL in 1 CARTON (13533-692-20) > 50 mL in 1 VIAL (13533-692-21) |
| Product NDC | 13533-692 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | Albumin (Human) |
| Dosage Form Name | SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19940926 |
| Marketing Category Name | BLA |
| Labeler Name | Grifols Therapeutics Inc. |
| Substance Name | ALBUMIN (HUMAN) |
| Strength Number | 5 |
| Strength Unit | g/20mL |
| Pharmaceutical Classes | Human Serum Albumin [EPC],Increased Intravascular Volume [PE],Increased Oncotic Pressure [PE],Osmotic Activity [MoA],Serum Albumin [Chemical/Ingredient] |
